Monte Rosa Therapeutics Inc.
GLUE | NASDAQ
$12.26
+$0.13 (+1.07%)
At close: Sep 21, 2026, 4:00 PM ET
$12.34
+$0.08 (+0.65%)
Pre-market:
Sep 22, 2026, 5:22 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -205.62M | -130.01M | -38.63M | 20.95M | 24.17M | 6.15M | -72.7M | -119.39M | -130.41M | -135.28M | -135.35M | -132.88M | -125.32M | -116.61M | -108.5M | -101.16M | -93.68M | -85.61M | -73.96M | -70.17M | -56.89M | -43.85M |
Depreciation & Amortization | 10.16M | 8.34M | 8.36M | 8.33M | 8.34M | 8.27M | 8.12M | 7.91M | 7.64M | 6.97M | 6.22M | 5.45M | 4.65M | 4.14M | 3.75M | 3.48M | 3.03M | 2.61M | 2.13M | 1.55M | 1.14M | 740K |
Stock-Based Compensation | 26.54M | 19.52M | 18.87M | 19.03M | 18.94M | 18.55M | 18.13M | 17.73M | 17.92M | 17.57M | 16.67M | 15.92M | 14.67M | 13.39M | 11.66M | 10.19M | 9.05M | 7.2M | 5.2M | 3.55M | 1.52M | 595K |
Other Working Capital | 105.88M | 86.82M | 11.52M | 97.98M | -26.55M | 6.11M | 84.81M | 40.83M | 53.44M | 54.37M | 64.48M | 14.46M | 10.94M | 5.57M | -1.21M | -1.27M | 2.56M | 4.61M | 6.99M | 6.18M | 2.66M | -1.97M |
Other Non-Cash Items | -3.22M | -2.1M | -2.2M | -2.99M | -3.61M | -3.97M | -2.95M | -991K | -399K | -743K | -1.81M | -2.72M | -1.02M | 1.42M | 2.76M | 2.41M | 1.22M | 226K | 977K | 8.65M | 8.64M | 8.64M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2M | -2M | -2M | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K |
Change in Working Capital | 110.71M | 89.59M | -9.19M | 103.83M | -20.12M | 5.66M | 91.4M | 39.45M | 46.25M | 54.93M | 72.47M | 16.84M | 13.73M | 9.19M | -2.13M | 2.39M | 501K | 2.63M | 6.29M | 2.67M | 2.74M | 386K |
Operating Cash Flow | -61.44M | -14.68M | -22.8M | 149.14M | 27.72M | 34.67M | 42M | -57.29M | -61M | -58.56M | -43.8M | -97.4M | -93.29M | -88.47M | -92.47M | -82.68M | -79.87M | -72.95M | -59.36M | -53.77M | -42.86M | -33.49M |
Capital Expenditures | -9.88M | -4.98M | -4.7M | -4.12M | -3.86M | -4.19M | -3.99M | -5.49M | -6.75M | -11.18M | -18.98M | -24.56M | -24.32M | -20.42M | -12.8M | -8.66M | -9M | -9.14M | -9.8M | -7.86M | -7.03M | -5.59M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.99K | -15.99K | 46.01K | 46.01K | 108.67K | 92.67K | 30.67K | 155.67K | 121K | 137K | 137K | 12K | n/a | n/a | n/a |
Purchase of Investments | -959.7M | -570.66M | -376.68M | -290.98M | -257.38M | -312.31M | -230.36M | -189.91M | -165.35M | -91.4M | -103.15M | -170.01M | -221.59M | -273.28M | -384.42M | -290.05M | -230.65M | -178.96M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 391.79M | 313.04M | 279.54M | 227.43M | 193.19M | 161.96M | 189.9M | 196.15M | 170.73M | 180.91M | 210.93M | 215.13M | 260.33M | 275.33M | 178M | 130.3M | 40M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.99K | 15.99K | 15.99K | 15.99K | -46.67K | -46.67K | -46.67K | -46.67K | n/a | 67K | 67K | 67K | 67K | n/a | n/a |
Investing Cash Flow | -577.78M | -262.6M | -101.83M | -67.66M | -68.05M | -154.53M | -44.45M | 741K | -1.38M | 78.33M | 88.8M | 20.57M | 14.43M | -18.37M | -219.22M | -168.33M | -199.5M | -187.96M | -9.65M | -7.79M | -7.03M | -5.59M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -178K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -387K | n/a | n/a | 47.61M | 47.61M | 47.61M | 47.61M | n/a | n/a | n/a | n/a | 379K | 379K | 379K | 379K | n/a | -1.56M | 203.92M | 203.92M | 203.91M | 205.21M | -440K |
Financial Cash Flow | 689.85M | 358.67M | 30.35M | 1.34M | 1M | 98.66M | 98.89M | 123.46M | 124.54M | 27.72M | 27.49M | 22.75M | 21.44M | 20.33M | 20.47M | -103K | 29.57M | 234.95M | 377.56M | 377.69M | 395.98M | 202.83M |
Net Cash Flow | 50.64M | 81.4M | -94.3M | 82.79M | -39.35M | -21.23M | 96.15M | 66.56M | 61.82M | 46.95M | 72.23M | -54.28M | -56.62M | -85.48M | -290.18M | -253.68M | -253.4M | -30.13M | 304.37M | 315.57M | 345.52M | 163.74M |
Free Cash Flow | -71.32M | -19.66M | -27.5M | 145.02M | 23.85M | 30.48M | 38.01M | -62.79M | -67.76M | -69.74M | -62.78M | -121.96M | -117.61M | -108.89M | -105.27M | -91.33M | -88.87M | -82.1M | -69.16M | -61.62M | -49.9M | -39.09M |
Adj. Free Cash Flow | -97.86M | -39.17M | -46.36M | 126M | 4.91M | 11.93M | 19.88M | -80.52M | -85.68M | -87.31M | -79.45M | -137.88M | -132.28M | -122.28M | -116.93M | -101.53M | -97.92M | -89.3M | -74.36M | -65.17M | -51.41M | -39.68M |
Maintenance CapEx | -6.58M | -2.64M | -767K | n/a | n/a | n/a | n/a | -1.69M | -3.35M | -4.74M | -5.89M | -5.27M | -4.65M | -4.14M | -3.75M | -3.48M | -3.03M | -2.61M | -2.13M | -1.55M | -1.14M | -740K |
Growth CapEx | -3.3M | -2.35M | -3.93M | -4.12M | -3.86M | -4.19M | -3.99M | -3.81M | -3.41M | -6.44M | -13.09M | -19.29M | -19.67M | -16.28M | -9.06M | -5.17M | -5.96M | -6.53M | -7.67M | -6.31M | -5.9M | -4.85M |
Owner Earnings | -68.02M | -17.31M | -23.57M | 149.14M | 27.72M | 34.67M | 42M | -58.98M | -64.35M | -63.3M | -49.69M | -102.67M | -97.94M | -92.61M | -96.21M | -86.16M | -82.9M | -75.56M | -61.5M | -55.31M | -44M | -34.23M |
Add to Watchlist
Select watchlists to add or remove GLUE